Masfufatun Masfufatun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Masfufatun Masfufatun has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Rini Purbowati
Biomedical Department and Biomolecular Research, Faculty of Medicine, Universitas Wijaya Kusuma Surabaya, Surabaya
6 shared publications Lusiani Tjandra
5 shared publications- Lusiani Tjandra
Department of Pharmacology, Faculty of Medicine, Universitas Wijaya Kusuma Surabaya, Indonesia
4 shared publications Diana Tri Ratnasari
Universitas Wijaya Kusuma Surabaya
3 shared publications- Noer Kumala Indahsari
Departemen Biokimia, Fakultas Kedokteran, Universitas Wijaya Kusuma Surabaya
3 shared publications - Noer Kumala Indahsari
Faculty of Medicine, University of Wijaya Kusuma Surabaya
3 shared publications
Latest Publications
- Open Access
- 6 July 2026
- Published by Politeknik Kesehatan Kementerian Kesehatan Surabaya in Gema Lingkungan Kesehatan
- Vol. 24 (3) , 474-481
Red Ginger Extract Nanoemulgel: Antibacterial and Wound-Healing Efficacy Against Staphylococcus aureus in a Preclinical Mouse Model
Wound infections by Staphylococcus aureus (St. aureus), exacerbated by biofilm formation and antibiotic resistance, are a major challenge in wound management. This study aims to test the efficacy of Red Ginger Extract Nanoemulgel (RGE Nanoemulgel) as a new topical agent in controlling bacterial infections and accelerating the healing of experimentally induced infected incision wounds in a preclinical mouse model. The study comprised in vitro antibacterial and anti-biofilm activity assays comparing RGE Nanoemulsion against Gentamicin, followed by in vivo efficacy testing in an animal model comparing RGE Nanoemulgel, RGE, and Mupirocin in terms of bacterial abundance (log CFU/gram) and wound contraction percentage. Results indicated that RGE Nanoemulsion demonstrated promising in vitro antimicrobial activity; at a concentration of 25%, antibacterial inhibition reached 75.11% (exceeding Gentamicin at 51.18%), and anti-biofilm inhibition reached 90.79% at 50% concentration. In vivo, RGE Nanoemulgel suppressed bacterial abundance to 3.96 log CFU/gram, comparable to Mupirocin, and achieved a wound contraction rate of 93.50% on Day 12, exceeding Mupirocin (63.16%). These preclinical findings suggest that RGE Nanoemulgel may represent a promising non-antibiotic topical candidate, combining antibacterial, anti-biofilm, and wound-supportive properties. Further toxicity, stability, and clinical validation studies are warranted before therapeutic claims can be established.
- 6 July 2026
- Published by Politeknik Kesehatan Kementerian Kesehatan Surabaya in Gema Lingkungan Kesehatan
- Vol. 24 (3) , 474-481
Open AccessRed Ginger Extract Nanoemulgel: Antibacterial and Wound-Healing Efficacy Against Staphylococcus aureus in a Preclinical Mouse Model
Wound infections by Staphylococcus aureus (St. aureus), exacerbated by biofilm formation and antibiotic resistance, are a major challenge in wound management. This study aims to test the efficacy of Red Ginger Extract Nanoemulgel (RGE Nanoemulgel) as a new topical agent in controlling bacterial infections and accelerating the healing of experimentally induced infected incision wounds in a preclinical mouse model. The study comprised in vitro antibacterial and anti-biofilm activity assays comparing RGE Nanoemulsion against Gentamicin, followed by in vivo efficacy testing in an animal model comparing RGE Nanoemulgel, RGE, and Mupirocin in terms of bacterial abundance (log CFU/gram) and wound contraction percentage. Results indicated that RGE Nanoemulsion demonstrated promising in vitro antimicrobial activity; at a concentration of 25%, antibacterial inhibition reached 75.11% (exceeding Gentamicin at 51.18%), and anti-biofilm inhibition reached 90.79% at 50% concentration. In vivo, RGE Nanoemulgel suppressed bacterial abundance to 3.96 log CFU/gram, comparable to Mupirocin, and achieved a wound contraction rate of 93.50% on Day 12, exceeding Mupirocin (63.16%). These preclinical findings suggest that RGE Nanoemulgel may represent a promising non-antibiotic topical candidate, combining antibacterial, anti-biofilm, and wound-supportive properties. Further toxicity, stability, and clinical validation studies are warranted before therapeutic claims can be established.
- Open Access
- 6 January 2026
- Published by Universitas Mataram in Jurnal Biologi Tropis
- Vol. 26 (1) , 605-613
Development of Curcuma xanthorrhiza Nanoemulsion as an Antibiofilm Agent against Multidrug-Resistant Candida albicans: Formulation Approach and In Vitro Evaluation
Candida albicans infection is a serious health concern, particularly in immunocompromised individuals, due to its ability to form biofilms that are resistant to conventional antifungal therapies. Curcuma xanthorrhiza Roxb. (temulawak) possesses antifungal properties; however, its effectiveness is limited by poor solubility and bioavailability. Nanoemulsion formulation offers a promising strategy to enhance the penetration of active compounds. This study aimed to develop and evaluate the effectiveness of temulawak nanoemulsion as an antibiofilm agent against multidrug-resistant (MDR) C. albicans. Using a post-test control group only design, the antibiofilm assay was conducted via the microtiter plate method and analyzed based on Optical Density (OD) measurements. The results showed that temulawak nanoemulsion significantly reduced biofilm formation, with an 89% reduction in OD at the 100% concentration. These findings support the potential use of temulawak nanoemulsion as an alternative therapeutic strategy for Candida albicans infections, particularly those involving drug-resistant biofilms.
- 6 January 2026
- Published by Universitas Mataram in Jurnal Biologi Tropis
- Vol. 26 (1) , 605-613
Open AccessDevelopment of Curcuma xanthorrhiza Nanoemulsion as an Antibiofilm Agent against Multidrug-Resistant Candida albicans: Formulation Approach and In Vitro Evaluation
Candida albicans infection is a serious health concern, particularly in immunocompromised individuals, due to its ability to form biofilms that are resistant to conventional antifungal therapies. Curcuma xanthorrhiza Roxb. (temulawak) possesses antifungal properties; however, its effectiveness is limited by poor solubility and bioavailability. Nanoemulsion formulation offers a promising strategy to enhance the penetration of active compounds. This study aimed to develop and evaluate the effectiveness of temulawak nanoemulsion as an antibiofilm agent against multidrug-resistant (MDR) C. albicans. Using a post-test control group only design, the antibiofilm assay was conducted via the microtiter plate method and analyzed based on Optical Density (OD) measurements. The results showed that temulawak nanoemulsion significantly reduced biofilm formation, with an 89% reduction in OD at the 100% concentration. These findings support the potential use of temulawak nanoemulsion as an alternative therapeutic strategy for Candida albicans infections, particularly those involving drug-resistant biofilms.
- Open Access
- 24 November 2025
- Published by Universitas Padjadjaran in Padjadjaran Journal of Dentistry
- Vol. 37 (3) , 350-361
Comparative analysis of IL-6 levels in post-tooth extraction inflammation among menopausal and non-menopausal: in vivo experimental
Introduction: IL-6 acts as a biomarker of the inflammatory process. In elderly, especially women, the demand for tooth extraction treatment is quite high. A failure in the wound healing process during the menopausal period can prolong the inflammation process, thereby increasing the probability of infection, including alveolar osteitis. The menopausal process affects estrogen levels in the blood, which leads to reduced collagen formation as a key component of tissue regeneration. IL-6 levels can also increase during inflammation, especially in the chronic phase following tooth extraction. The study aims to analyze the differences in inflammatory IL-6 levels between menopausal and non-menopausal rats. Methods: This study applied an in vivo experimental design. A total of 30 Rattus novergicus were divided into two groups: a control group and a treatment group. The control group consisted of rats in which no oophorectomy was performed (non-menopausal), while the treatment group underwent ovariectomy to induce menopause. One after the procedure, tooth extraction were performed, and observations were conducted on days 3, 7, and 14 post-extractions. IL-6 levels were measured using ELISA from blood serum samples. The data were analyzed using One-Way ANOVA. Results: The average IL-6 levels (in ng/L) in the control (non-menopausal) group on days 3, 7, and 14 were 0.087, 0.318, and 0.247, respectively. The average IL-6 levels in the treatment (menopausal) group were 0.191, 0.452, and 0.318, respectively. The One-Way ANOVA test showed no significant difference between the groups (p=0.799 > 0.05). Conclusion: The trend of higher IL-6 levels in the menopausal group suggests a potential impact of hormonal changes on post-extraction inflammation. Although no significant difference was found, the elevated IL-6 levels in menopausal rats indicate a potential effect of estrogen deficiency on the inflammatory response following tooth extraction.
- 24 November 2025
- Published by Universitas Padjadjaran in Padjadjaran Journal of Dentistry
- Vol. 37 (3) , 350-361
Open AccessComparative analysis of IL-6 levels in post-tooth extraction inflammation among menopausal and non-menopausal: in vivo experimental
Introduction: IL-6 acts as a biomarker of the inflammatory process. In elderly, especially women, the demand for tooth extraction treatment is quite high. A failure in the wound healing process during the menopausal period can prolong the inflammation process, thereby increasing the probability of infection, including alveolar osteitis. The menopausal process affects estrogen levels in the blood, which leads to reduced collagen formation as a key component of tissue regeneration. IL-6 levels can also increase during inflammation, especially in the chronic phase following tooth extraction. The study aims to analyze the differences in inflammatory IL-6 levels between menopausal and non-menopausal rats. Methods: This study applied an in vivo experimental design. A total of 30 Rattus novergicus were divided into two groups: a control group and a treatment group. The control group consisted of rats in which no oophorectomy was performed (non-menopausal), while the treatment group underwent ovariectomy to induce menopause. One after the procedure, tooth extraction were performed, and observations were conducted on days 3, 7, and 14 post-extractions. IL-6 levels were measured using ELISA from blood serum samples. The data were analyzed using One-Way ANOVA. Results: The average IL-6 levels (in ng/L) in the control (non-menopausal) group on days 3, 7, and 14 were 0.087, 0.318, and 0.247, respectively. The average IL-6 levels in the treatment (menopausal) group were 0.191, 0.452, and 0.318, respectively. The One-Way ANOVA test showed no significant difference between the groups (p=0.799 > 0.05). Conclusion: The trend of higher IL-6 levels in the menopausal group suggests a potential impact of hormonal changes on post-extraction inflammation. Although no significant difference was found, the elevated IL-6 levels in menopausal rats indicate a potential effect of estrogen deficiency on the inflammatory response following tooth extraction.
- Open Access
- 28 July 2025
- Published by Politeknik Kesehatan Kementerian Kesehatan Surabaya in Gema Lingkungan Kesehatan
- Vol. 23 (3) , 350-356
Effectiveness of Cardamom Ethanol Extract (Amomum compactum Soland Ex Maton) in Inhibiting the Growth of Candida albicans Biofilm
Cardamom (Amomum compactum Soland Ex Maton) is a spice known for its pharmacological properties. It contains bioactive compounds such as flavonoids, alkaloids, saponins, terpenoids, and tannins, which have the potential antibiofilms activity. This study aims to evaluate the effectiveness of cardamom ethanol extract in inhibiting the growth of Candida albicans biofilm. A true experimental design with a post-test only control group design approach was employed. The extraction method used is the maceration method, and biofilm inhibition was assessed using the microtiter plate biofilm assay method. The Optical Density (OD) value was measured at 595 nm using a microplate reader . The results indicate that cardamom ethanol extract significantly inhibited C. albicans biofilm growth (p<0.05). The highestinhibition was observed at a 50% concentration of Cardamom extract. Probits analysis revealed the minimum biofilm inhibitory concentration (MBIC50 ) of cardamom extract to be 21.768%. In conclusion, cardamom ethanol extract is effective in inhibiting C. albicans biofilm formation with significant activity observed at concentration as low as 3.175, with the highest efficacy at 50%. Thus, cardamom ethanol extract can be used as an antibiofilm for the treatment of various infectious diseases caused by C. albicans biofilm. The findings suggest that cardamom ethanol extract could serve as a promising candidate for the development of novel antibiofilm agents targeting C. albicans infections. Further research, particularly in vivo studies, is necessary to validate its therapeutic potential and explore its mechanism of action in clinical settings.
- 28 July 2025
- Published by Politeknik Kesehatan Kementerian Kesehatan Surabaya in Gema Lingkungan Kesehatan
- Vol. 23 (3) , 350-356
Open AccessEffectiveness of Cardamom Ethanol Extract (Amomum compactum Soland Ex Maton) in Inhibiting the Growth of Candida albicans Biofilm
Cardamom (Amomum compactum Soland Ex Maton) is a spice known for its pharmacological properties. It contains bioactive compounds such as flavonoids, alkaloids, saponins, terpenoids, and tannins, which have the potential antibiofilms activity. This study aims to evaluate the effectiveness of cardamom ethanol extract in inhibiting the growth of Candida albicans biofilm. A true experimental design with a post-test only control group design approach was employed. The extraction method used is the maceration method, and biofilm inhibition was assessed using the microtiter plate biofilm assay method. The Optical Density (OD) value was measured at 595 nm using a microplate reader . The results indicate that cardamom ethanol extract significantly inhibited C. albicans biofilm growth (p<0.05). The highestinhibition was observed at a 50% concentration of Cardamom extract. Probits analysis revealed the minimum biofilm inhibitory concentration (MBIC50 ) of cardamom extract to be 21.768%. In conclusion, cardamom ethanol extract is effective in inhibiting C. albicans biofilm formation with significant activity observed at concentration as low as 3.175, with the highest efficacy at 50%. Thus, cardamom ethanol extract can be used as an antibiofilm for the treatment of various infectious diseases caused by C. albicans biofilm. The findings suggest that cardamom ethanol extract could serve as a promising candidate for the development of novel antibiofilm agents targeting C. albicans infections. Further research, particularly in vivo studies, is necessary to validate its therapeutic potential and explore its mechanism of action in clinical settings.
- Open Access
- 30 May 2025
- Published by Universitas Hang Tuah in Hang Tuah Medical journal
- Vol. 22 (2) , 271-285
Effectiveness of Ethanol Extract of Temulawak Rhizome as Antibiofilm Against Candida Albicans, the Cause of Candidiasis
Curcuma (Curcuma xanthorrhiza Roxb) is a type of herbal plant that can be used to control infections from C. albicans, because it contains alkaloids, flavonoids, phenolics, saponins, triterpennoids, and glycosides. The purpose of this study is to analyze the effectiveness of temulawak rhizome ethanol extract as an antibiofilm against Candida alibicans, which causes candidiasis. The research design used is purely experimental with a post test control group only design approach. The extraction method used is maceration with 96% ethanol solvent, the antibiofilm activity test uses the microtiter plate biofilm assay method. The measurement of Optical Density (OD) of the antibiofilm activity test results was carried out with a microplate reader at a wavelength of 595nm. The data was analyzed using SPSS for Windows V29.02. The results showed that Temulawak ethanol extract (Curcuma xanthorrhiza Roxb) had a significant effect on the formation of C. albicans biofilm (p<0.05) with the highest inhibition at a concentration of 1.56%, and the smallest value at a concentration of 50%. The MBIC50 value was determined by probit analysis, so that the concentration of Temulawak ethanol extract (Curcuma xanthorrhiza Roxb) which can inhibit 50% of the formation of C. albicans biofilm is located at a concentration of 0.031%. Thus, it can be concluded that Temulawak rhizome ethanol extract has antibiofilm effectiveness against C. albicans, which causes candidiasis at the stage of biofilm formation. Thus, ethanol extract of temulawak rhizome has the potential to be used as an herbal medicine for the treatment of infectious diseases caused by C. albicans biofilm.
- 30 May 2025
- Published by Universitas Hang Tuah in Hang Tuah Medical journal
- Vol. 22 (2) , 271-285
Open AccessEffectiveness of Ethanol Extract of Temulawak Rhizome as Antibiofilm Against Candida Albicans, the Cause of Candidiasis
Curcuma (Curcuma xanthorrhiza Roxb) is a type of herbal plant that can be used to control infections from C. albicans, because it contains alkaloids, flavonoids, phenolics, saponins, triterpennoids, and glycosides. The purpose of this study is to analyze the effectiveness of temulawak rhizome ethanol extract as an antibiofilm against Candida alibicans, which causes candidiasis. The research design used is purely experimental with a post test control group only design approach. The extraction method used is maceration with 96% ethanol solvent, the antibiofilm activity test uses the microtiter plate biofilm assay method. The measurement of Optical Density (OD) of the antibiofilm activity test results was carried out with a microplate reader at a wavelength of 595nm. The data was analyzed using SPSS for Windows V29.02. The results showed that Temulawak ethanol extract (Curcuma xanthorrhiza Roxb) had a significant effect on the formation of C. albicans biofilm (p<0.05) with the highest inhibition at a concentration of 1.56%, and the smallest value at a concentration of 50%. The MBIC50 value was determined by probit analysis, so that the concentration of Temulawak ethanol extract (Curcuma xanthorrhiza Roxb) which can inhibit 50% of the formation of C. albicans biofilm is located at a concentration of 0.031%. Thus, it can be concluded that Temulawak rhizome ethanol extract has antibiofilm effectiveness against C. albicans, which causes candidiasis at the stage of biofilm formation. Thus, ethanol extract of temulawak rhizome has the potential to be used as an herbal medicine for the treatment of infectious diseases caused by C. albicans biofilm.
- Open Access
- 18 February 2025
- Published by Al-Jamiah Research Centre in Biology, Medicine, & Natural Product Chemistry
- Vol. 14 (1) , 123-127
Synergistic Anti-Biofilm Activity of Klanceng Honey and Probiotics against Candida albicans
Candida albicans is a common cause of fungal infections, especially in hospitals. Biofilm formation by this fungus is a significant problem as it leads to increased drug resistance and complications in treatment. The biofilm's extracellular matrix protects the fungal cells, making it difficult for antifungal drugs to penetrate and clear the infection. Aim: This study investigates the potential of honey and probiotic formulations to inhibit the biofilm matrix formation in Candida albicans. Result: Klanceng honey showed the strongest inhibition of Candida albicans biofilm formation, reducing it by 89.39% (OD = 0.34 0.10), compared to yogurt (29.43%, OD = 2.25 0.16) and Yakult (67.95%, OD = 1.02 0.25) (p < 0.05). When mixed with yogurt in a 5:1:2 ratio (honey:yogurt: water), Klanceng honey reduced biofilm formation by 84.92% (OD = 0.50 0.12). Manuka and Melifera honey in the same ratio also showed strong inhibition, reducing biofilm formation by 77.84% (OD = 0.73 0.08) and 90.52% (OD = 0.31 0.07), respectively. This performance exceeded fluconazoles, which achieved a 65.52% reduction (OD = 1.14 0.02). For all three honey types, the 4:1:3 and 2:1:5 ratios (honey:Yakult: water) were more effective, with reductions of up to 80.96% for Melifera and 75.64% for Klanceng (p < 0.05). Conclusion: This research suggests that honey and probiotic formulations hold promise as natural alternatives in combating Candida albicans infections. The study found that the ratio of honey to probiotics in the formulations significantly influenced their effectiveness.
- 18 February 2025
- Published by Al-Jamiah Research Centre in Biology, Medicine, & Natural Product Chemistry
- Vol. 14 (1) , 123-127
Open AccessSynergistic Anti-Biofilm Activity of Klanceng Honey and Probiotics against Candida albicans
Candida albicans is a common cause of fungal infections, especially in hospitals. Biofilm formation by this fungus is a significant problem as it leads to increased drug resistance and complications in treatment. The biofilm's extracellular matrix protects the fungal cells, making it difficult for antifungal drugs to penetrate and clear the infection. Aim: This study investigates the potential of honey and probiotic formulations to inhibit the biofilm matrix formation in Candida albicans. Result: Klanceng honey showed the strongest inhibition of Candida albicans biofilm formation, reducing it by 89.39% (OD = 0.34 0.10), compared to yogurt (29.43%, OD = 2.25 0.16) and Yakult (67.95%, OD = 1.02 0.25) (p < 0.05). When mixed with yogurt in a 5:1:2 ratio (honey:yogurt: water), Klanceng honey reduced biofilm formation by 84.92% (OD = 0.50 0.12). Manuka and Melifera honey in the same ratio also showed strong inhibition, reducing biofilm formation by 77.84% (OD = 0.73 0.08) and 90.52% (OD = 0.31 0.07), respectively. This performance exceeded fluconazoles, which achieved a 65.52% reduction (OD = 1.14 0.02). For all three honey types, the 4:1:3 and 2:1:5 ratios (honey:Yakult: water) were more effective, with reductions of up to 80.96% for Melifera and 75.64% for Klanceng (p < 0.05). Conclusion: This research suggests that honey and probiotic formulations hold promise as natural alternatives in combating Candida albicans infections. The study found that the ratio of honey to probiotics in the formulations significantly influenced their effectiveness.
- Open Access
- 1 January 2025
- Published by ScopeMed in Open Veterinary Journal
- Vol. 15 (5) , 2182
Mechanism of recombinant 1,3-β-glucanase as antibiofilm to prevent antimicrobial resistance in antifungal therapy for vulvovaginitis candidiasis
Background: Candida albicans is an opportunistic pathogen that can form biofilms, thereby increasing resistance to antifungals such as fluconazole. The extracellular matrix of biofilms rich in β-1,3-glucans is the main barrier to the penetration of antifungal drugs. Aim: This study aimed to study the mechanism of recombinant β-1,3-glucanase activity as an antibiofilm agent to increase the effectiveness of antifungals in treating vulvovaginitis candidiasis (VVC). Methods: Recombinant β-1,3-glucanase was produced using recombinant DNA technology and tested for its antibiofilm activity against C. albicans biofilms. Tests were carried out at the adhesion stage, biofilm formation, and mature biofilm using the crystal violet assay, scanning electron microscope (SEM), confocal laser scanning microscope (CLSM) methods, and cell viability tests. The combination of β-1,3-glucanase with fluconazole was also evaluated to measure its synergistic effect on biofilm matrix degradation and cell viability. Results: The results showed that recombinant β-1,3-glucanase affected all stages of C. albicans biofilm formation. Recombinant β-1,3-glucanase was able to inhibit biofilm matrix formation by 86.05% and reduce C. albicans cell viability by 75.43% when combined with fluconazole. SEM and CLSM analyses revealed significant damage to the 3D structure of the biofilm, demonstrating the synergistic effectiveness of the combination of the two agents. The combination of recombinant β-1,3-glucanase with fluconazole in vitro was shown to be effective in inhibiting biofilm formation and eradicating mature C. albicans biofilms. Conclusion: These findings indicate the great potential of β-1,3-glucanase to be applied as an antifungal concomitant agent for overcoming antimicrobial resistance in biofilm infections such as VVC. Further studies are needed to evaluate the effectiveness of the drug in in vivo models and clinical applications.
- 1 January 2025
- Published by ScopeMed in Open Veterinary Journal
- Vol. 15 (5) , 2182
Open AccessMechanism of recombinant 1,3-β-glucanase as antibiofilm to prevent antimicrobial resistance in antifungal therapy for vulvovaginitis candidiasis
Background: Candida albicans is an opportunistic pathogen that can form biofilms, thereby increasing resistance to antifungals such as fluconazole. The extracellular matrix of biofilms rich in β-1,3-glucans is the main barrier to the penetration of antifungal drugs. Aim: This study aimed to study the mechanism of recombinant β-1,3-glucanase activity as an antibiofilm agent to increase the effectiveness of antifungals in treating vulvovaginitis candidiasis (VVC). Methods: Recombinant β-1,3-glucanase was produced using recombinant DNA technology and tested for its antibiofilm activity against C. albicans biofilms. Tests were carried out at the adhesion stage, biofilm formation, and mature biofilm using the crystal violet assay, scanning electron microscope (SEM), confocal laser scanning microscope (CLSM) methods, and cell viability tests. The combination of β-1,3-glucanase with fluconazole was also evaluated to measure its synergistic effect on biofilm matrix degradation and cell viability. Results: The results showed that recombinant β-1,3-glucanase affected all stages of C. albicans biofilm formation. Recombinant β-1,3-glucanase was able to inhibit biofilm matrix formation by 86.05% and reduce C. albicans cell viability by 75.43% when combined with fluconazole. SEM and CLSM analyses revealed significant damage to the 3D structure of the biofilm, demonstrating the synergistic effectiveness of the combination of the two agents. The combination of recombinant β-1,3-glucanase with fluconazole in vitro was shown to be effective in inhibiting biofilm formation and eradicating mature C. albicans biofilms. Conclusion: These findings indicate the great potential of β-1,3-glucanase to be applied as an antifungal concomitant agent for overcoming antimicrobial resistance in biofilm infections such as VVC. Further studies are needed to evaluate the effectiveness of the drug in in vivo models and clinical applications.
- Open Access
- 26 December 2024
- Published by Rumah Sakit Penyakit Infeksi Prof Dr. Sulianti Saroso in The Indonesian Journal of Infectious Diseases
- Vol. 10 (2) , 141-152
Identifikasi Spesies Candida Pada Pasien Kandidiasis Vulvovaginalis dan Faktor Risikonya
Latar belakang: Candidiasis Vulvovaginalis (KVV) merupakan infeksi pada vulva dan/atau vagina akibat pertumbuhan berlebih dari Candida sp, terutama pada wanita usia reproduksi. Penyakit ini dapat mengganggu kesehatan fisik dan mental penderita. Berbagai laporan menyatakan bahwa Candida albicans merupakan agen aktif etiologi utama pada infeksi ini. Namun, spesies non-Candida albicans baru-baru ini muncul. Jadi tampaknya ada perubahan pola spesies Candida pada KVV. Tujuan: menganalisis faktor risiko dan mengidentifikasi spesies Candida pada pasien KVV di Surabaya. Metode: Penelitian ini merupakan penelitian analitik dengan desain cross-sectional yang melibatkan 67 subjek penelitian dari pasien Klinik Ibu dan Anak Surabaya dengan keluhan keputihan. Pengumpulan data dilakukan dengan metode anamnesis, pengisian kuesioner, pemeriksaan fisik dan klinis, serta pemeriksaan laboratorium. Sampel sekresi/keputihan vagina pasien diambil menggunakan usapan steril dan diperiksa secara mikrobiologis dengan menumbuhkannya pada media Sabraoud Dextrose Agar (SDA). Isolat yang tumbuh pada media SDA diidentifikasi sebagai spesies Candida melalui produksi Chlamydoconidia pada media Corn Meal Agar, pembentukan tabung germinal dan kultur pada CHROMAgar. Analisis data faktor risiko dilakukan dengan menggunakan uji chi-square dengan tingkat signifikansi pHasil: Sebanyak 26 (38,84%) sampel dari 67 pasien dinyatakan positif KVV. Frekuensi tertinggi berada pada rentang usia 25 hingga 45 tahun, menggunakan kontrasepsi dan douches vagina. Gejala yang paling umum di antara pasien adalah keputihan abnormal dan iritasi vagina yang berhubungan dengan keputihan abnormal. Ada hubungan antara usia, penggunaan kontrasepsi, dan douches vagina dengan kejadian KVV (pCandida albicans (44,5%) dan Candida glabrata (42,4%) lebih dominan pada pasien KVV dibandingkan spesies Candida lainnya. Kesimpulan: Usia, pemakaian alat kontrasepsi dan obat pembersih vagina merupakan faktor resiko KVV. Spesies C. albicans dan C. glabrata mendominasi spesies candida hasil isolasi dari pasien KVV. Oleh karena itu hasil klinis dan laboratorium perlu diperhatikan dan dipertimbangkan dalam memberikan pengobatan terbaik.
- 26 December 2024
- Published by Rumah Sakit Penyakit Infeksi Prof Dr. Sulianti Saroso in The Indonesian Journal of Infectious Diseases
- Vol. 10 (2) , 141-152
Open AccessIdentifikasi Spesies Candida Pada Pasien Kandidiasis Vulvovaginalis dan Faktor Risikonya
Latar belakang: Candidiasis Vulvovaginalis (KVV) merupakan infeksi pada vulva dan/atau vagina akibat pertumbuhan berlebih dari Candida sp, terutama pada wanita usia reproduksi. Penyakit ini dapat mengganggu kesehatan fisik dan mental penderita. Berbagai laporan menyatakan bahwa Candida albicans merupakan agen aktif etiologi utama pada infeksi ini. Namun, spesies non-Candida albicans baru-baru ini muncul. Jadi tampaknya ada perubahan pola spesies Candida pada KVV. Tujuan: menganalisis faktor risiko dan mengidentifikasi spesies Candida pada pasien KVV di Surabaya. Metode: Penelitian ini merupakan penelitian analitik dengan desain cross-sectional yang melibatkan 67 subjek penelitian dari pasien Klinik Ibu dan Anak Surabaya dengan keluhan keputihan. Pengumpulan data dilakukan dengan metode anamnesis, pengisian kuesioner, pemeriksaan fisik dan klinis, serta pemeriksaan laboratorium. Sampel sekresi/keputihan vagina pasien diambil menggunakan usapan steril dan diperiksa secara mikrobiologis dengan menumbuhkannya pada media Sabraoud Dextrose Agar (SDA). Isolat yang tumbuh pada media SDA diidentifikasi sebagai spesies Candida melalui produksi Chlamydoconidia pada media Corn Meal Agar, pembentukan tabung germinal dan kultur pada CHROMAgar. Analisis data faktor risiko dilakukan dengan menggunakan uji chi-square dengan tingkat signifikansi pHasil: Sebanyak 26 (38,84%) sampel dari 67 pasien dinyatakan positif KVV. Frekuensi tertinggi berada pada rentang usia 25 hingga 45 tahun, menggunakan kontrasepsi dan douches vagina. Gejala yang paling umum di antara pasien adalah keputihan abnormal dan iritasi vagina yang berhubungan dengan keputihan abnormal. Ada hubungan antara usia, penggunaan kontrasepsi, dan douches vagina dengan kejadian KVV (pCandida albicans (44,5%) dan Candida glabrata (42,4%) lebih dominan pada pasien KVV dibandingkan spesies Candida lainnya. Kesimpulan: Usia, pemakaian alat kontrasepsi dan obat pembersih vagina merupakan faktor resiko KVV. Spesies C. albicans dan C. glabrata mendominasi spesies candida hasil isolasi dari pasien KVV. Oleh karena itu hasil klinis dan laboratorium perlu diperhatikan dan dipertimbangkan dalam memberikan pengobatan terbaik.
- Open Access
- 28 November 2024
- Published by Universitas Hang Tuah in Hang Tuah Medical journal
- Vol. 22 (1) , 1-14
Efek Sinergis Vitamin C Dalam Meningkatkan Kinerja Antijamur Madu Apis dorsata Terhadap Biofilm Candida albicans Untuk Terapi Kandidiasis
Madu merupakan bahan alami yang dihasilkan oleh lebah dari nektar bunga yang memiliki sifat antimikroba, antioksidan, antiinflamasi, efek penyembuh luka yang baik, dan bakteriostatik. Penelitian ini bertujuan untuk mengetahui efek sinergis vitamin C dalam meningkatkan kinerja antijamur madu Apis dorsata terhadap biofilm Candida albicans untuk terapi kandidiasis. Desain penelitian ini true experimental dengan pendekatan post-test only control group design menggunakan metode microtiter plate assay untuk mengukur nilai Optical Density (OD) matriks biofilm. Uji efek sinergis Vitamin C terhadap Madu dilakukan dengan menambahkan vitamin C pada madu konsentrasi 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, dan 50%. Selanjutnya Nilai MBIC50 antara madu dan kombinasi madu dan vitamin C dibandingkan. Hasil penelitian menunjukkan bahwa baik madu maupun kombinasi madu dan vitamin C masing-masing mampu menurunkan pertumbuhan matriks biofilm C. albicans terhadap madu A. dorsata pada berbagai konsentrasi. Hasil nilai Minimum Biofilm Inhibitory Concentration 50% (MBIC50) pada madu A. dorsata dan kombinasi madu A.dorsata dan vitamin C masing-masing 84,27% dan 63,56%. Berdasarkan penelitian ini dapat disimpulkan bahwa vitamin C mampu menaikkan kinerja antijamur A. dorsata dengan menurunkan nilai MBIC50. Dengan demikian, kombinasi vitamin C dan madu dapat digunakan sebagai alternatif terapi kandidiasis.
- 28 November 2024
- Published by Universitas Hang Tuah in Hang Tuah Medical journal
- Vol. 22 (1) , 1-14
Open AccessEfek Sinergis Vitamin C Dalam Meningkatkan Kinerja Antijamur Madu Apis dorsata Terhadap Biofilm Candida albicans Untuk Terapi Kandidiasis
Madu merupakan bahan alami yang dihasilkan oleh lebah dari nektar bunga yang memiliki sifat antimikroba, antioksidan, antiinflamasi, efek penyembuh luka yang baik, dan bakteriostatik. Penelitian ini bertujuan untuk mengetahui efek sinergis vitamin C dalam meningkatkan kinerja antijamur madu Apis dorsata terhadap biofilm Candida albicans untuk terapi kandidiasis. Desain penelitian ini true experimental dengan pendekatan post-test only control group design menggunakan metode microtiter plate assay untuk mengukur nilai Optical Density (OD) matriks biofilm. Uji efek sinergis Vitamin C terhadap Madu dilakukan dengan menambahkan vitamin C pada madu konsentrasi 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, dan 50%. Selanjutnya Nilai MBIC50 antara madu dan kombinasi madu dan vitamin C dibandingkan. Hasil penelitian menunjukkan bahwa baik madu maupun kombinasi madu dan vitamin C masing-masing mampu menurunkan pertumbuhan matriks biofilm C. albicans terhadap madu A. dorsata pada berbagai konsentrasi. Hasil nilai Minimum Biofilm Inhibitory Concentration 50% (MBIC50) pada madu A. dorsata dan kombinasi madu A.dorsata dan vitamin C masing-masing 84,27% dan 63,56%. Berdasarkan penelitian ini dapat disimpulkan bahwa vitamin C mampu menaikkan kinerja antijamur A. dorsata dengan menurunkan nilai MBIC50. Dengan demikian, kombinasi vitamin C dan madu dapat digunakan sebagai alternatif terapi kandidiasis.
- Open Access
- 1 October 2024
- Published by Al-Jamiah Research Centre in Biology, Medicine, & Natural Product Chemistry
- Vol. 13 (2) , 407-413
Effectiveness of Ethanol Extract Clove Leaves (Syzygium aromaticum) In Inhibiting Biofilm of Candida Albicans ATCC 14053
Candida albicans is the most common type of Candida. It is a normal microbiota in the healthy human body that can become pathogenic when its balance is disturbed, causing an infection referred to as candidiasis. Antifungal resistance to biofilms is estimated to be 10,000 times that in planktonic form. Clove leaves (Syzygium aromatium) can treat infectious diseases, including candidiasis. This study aimed to analyze whether the ethanol extract of clove leaves (S. aromaticum) destroys the biofilm of C. albicans ATCC 14053. The research designwas pure experimental with a post test control group only design approach. The extraction method used was maceration. Test antibiofilm activity of ethanol extract of clove leaves using microtiter plate biofilm assay method. Measurement of results with a microplate reader was carried out using a wavelength of 595nm in accordance by the wavelength of crystal violet used as a colouring agent. The results showed that ethanol extract of clove leaves (S. aromaticum) has significant effectiveness against the maturation of C. albicans biofilm (p<0.05) with the highest percentage of activity at 20% concentration. The MBEC50 was determined by probit analysis, so the concentration of clove leaf ethanol extract (S. aromaticum) that can eradicate 50% of C. albicans biofilm is located at a concentration of 0.45%. The clinical benefits that can be developed from the results of this study are the potential use of clove leaf ethanol extract as an alternative therapy for C. albicans infection in the form of soap or ointment.
- 1 October 2024
- Published by Al-Jamiah Research Centre in Biology, Medicine, & Natural Product Chemistry
- Vol. 13 (2) , 407-413
Open AccessEffectiveness of Ethanol Extract Clove Leaves (Syzygium aromaticum) In Inhibiting Biofilm of Candida Albicans ATCC 14053
Candida albicans is the most common type of Candida. It is a normal microbiota in the healthy human body that can become pathogenic when its balance is disturbed, causing an infection referred to as candidiasis. Antifungal resistance to biofilms is estimated to be 10,000 times that in planktonic form. Clove leaves (Syzygium aromatium) can treat infectious diseases, including candidiasis. This study aimed to analyze whether the ethanol extract of clove leaves (S. aromaticum) destroys the biofilm of C. albicans ATCC 14053. The research designwas pure experimental with a post test control group only design approach. The extraction method used was maceration. Test antibiofilm activity of ethanol extract of clove leaves using microtiter plate biofilm assay method. Measurement of results with a microplate reader was carried out using a wavelength of 595nm in accordance by the wavelength of crystal violet used as a colouring agent. The results showed that ethanol extract of clove leaves (S. aromaticum) has significant effectiveness against the maturation of C. albicans biofilm (p<0.05) with the highest percentage of activity at 20% concentration. The MBEC50 was determined by probit analysis, so the concentration of clove leaf ethanol extract (S. aromaticum) that can eradicate 50% of C. albicans biofilm is located at a concentration of 0.45%. The clinical benefits that can be developed from the results of this study are the potential use of clove leaf ethanol extract as an alternative therapy for C. albicans infection in the form of soap or ointment.